Company intelligence / Profile preview

Notice

Ownership: Private
Employees: ~12
Development stage: Other

Overview

Notice is a Turkish-based notified body designated as NB 2764 under the EU Medical Device Regulation (MDR 2017/745) and previously under the Medical Device Directive (MDD 93/42/EEC). It provides conformity assessment services to medical device manufacturers seeking CE marking for market access in Europe. The company is accredited to ISO/IEC 17065 and ISO/IEC 17021 standards for product conformity and quality management system certification[1][2][7]. As of late 2023, it was newly designated under MDR[7].

Industry: Consulting

Partnerships

Works with medical device manufacturers seeking CE markingNo major pharmaceutical or biotech partnerships reported; operates as an independent notified body

Beyond the preview

Go deeper on Notice.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Notice.

Explore the full profile